menu

NEWS Archives

  • 2018-09-03
    NEWS
    ReguGene Co., Ltd. was established.
  • 2017-10-02
    NEWS
    2017/10/2–2018/3/31 Kyoto-Based Entrepreneurship Education Programs (Kyoto City) “Development of New Drugs to Control Gene Expression Related to Cancer etc. to Start-up a Company”
  • 2017-10-01
    NEWS
    2017/10/1–2018/3/31 Acceleration Transformative Research for Medical Innovation (ACT-MS) (Japan Agency for Medical Research and Development) “Creation of innovative anticancer drugs for Refractory Lung Cancer”
  • 2017-08-01
    NEWS
    2017/8/1–2020/3/31 Incubation Program (Kyoto University) “Drug Development Project Based on Pyrrole-Imidazole Polyamide Conjugates with Specific DNA Binding Capability”
  • 2017-04-01
    NEWS
    2017/4/1–2022/3/31 Basis for Supporting Innovative Drug Discovery and Life Science Research (Japan Agency for Medical Research and Development ) “Support for developing medicines by using libraries based on gene expression regulation and DNA sequence recognition”
  • 2014-10-22
    NEWS
    2014/10/22–2019/3/31 Basic Science and Platform Technology Program for Innovative Biological Medicine (Japan Agency for Medical Research and Development ) “Development of Innovative Polyamide Drugs Enabling to Control Gene Expression”